These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 15992555
41. The DEX/CRH test for major depression: a potentially useful diagnostic test. Mokhtari M, Arfken C, Boutros N. Psychiatry Res; 2013 Jul 30; 208(2):131-9. PubMed ID: 23291044 [Abstract] [Full Text] [Related]
42. Overweight and obesity affect treatment response in major depression. Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Zihl J, Pfister H, Unschuld PG, Holsboer F, Lucae S. Biol Psychiatry; 2007 Aug 15; 62(4):321-6. PubMed ID: 17241618 [Abstract] [Full Text] [Related]
43. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP. Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC. J Psychiatr Res; 2007 Aug 15; 41(1-2):131-43. PubMed ID: 16455105 [Abstract] [Full Text] [Related]
44. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation. Joffe R, Brown P, Bienenstock A, Mitton J. Biol Psychiatry; 1984 Mar 15; 19(3):347-52. PubMed ID: 6426532 [Abstract] [Full Text] [Related]
45. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M. Biol Psychiatry; 2007 Sep 01; 62(5):400-6. PubMed ID: 17188252 [Abstract] [Full Text] [Related]
46. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. J Psychiatr Res; 2003 Sep 01; 37(2):135-43. PubMed ID: 12842167 [Abstract] [Full Text] [Related]
47. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Batista DL, Riar J, Keil M, Stratakis CA. Pediatrics; 2007 Sep 01; 120(3):e575-86. PubMed ID: 17698579 [Abstract] [Full Text] [Related]
48. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool]. Babinski T, Paunović VR. Srp Arh Celok Lek; 1994 Sep 01; 122(11-12):341-3. PubMed ID: 17974414 [Abstract] [Full Text] [Related]
49. Polymorphisms of the glucocorticoid receptor gene and major depression. van Rossum EF, Binder EB, Majer M, Koper JW, Ising M, Modell S, Salyakina D, Lamberts SW, Holsboer F. Biol Psychiatry; 2006 Apr 15; 59(8):681-8. PubMed ID: 16580345 [Abstract] [Full Text] [Related]
50. Clinical outcome after trimipramine in patients with delusional depression - a pilot study. Frieboes RM, Sonntag A, Yassouridis A, Eap CB, Baumann P, Steiger A. Pharmacopsychiatry; 2003 Jan 15; 36(1):12-7. PubMed ID: 12649769 [Abstract] [Full Text] [Related]
51. The relationship between cognitive function and clinical and functional outcomes in major depressive disorder. Withall A, Harris LM, Cumming SR. Psychol Med; 2009 Mar 15; 39(3):393-402. PubMed ID: 18533056 [Abstract] [Full Text] [Related]
52. Cerebral ventricular size in major depressive disorder: association with delusional symptoms. Targum SD, Rosen LN, DeLisi LE, Weinberger DR, Citrin CM. Biol Psychiatry; 1983 Mar 15; 18(3):329-36. PubMed ID: 6404312 [Abstract] [Full Text] [Related]
53. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment. Escobar JI, Halaris A, Baxter L, Schwarcz G, Thompson M, Hurwicz ML, Hill M, Young M, Daugherty K, Clemens A. Psychopharmacol Bull; 1985 Mar 15; 21(1):77-80. PubMed ID: 3920706 [No Abstract] [Full Text] [Related]
54. Assessment of the validity of the dexamethasone/corticotropin-releasing hormone test. Comment on: Watson, S., Gallagher, P., Smith, M.S., Ferrier, I.N., Young, A.H., 2006. The dex/CRH test--is it better than the DST? Psychoneuroendocrinology 31, 889-894. Van Den Eede F, Claes SJ. Psychoneuroendocrinology; 2007 Jan 15; 32(1):91; author reply 92-4. PubMed ID: 17156938 [No Abstract] [Full Text] [Related]
55. The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression. Schüle C, Baghai TC, Eser D, Häfner S, Born C, Herrmann S, Rupprecht R. PLoS One; 2009 Jan 15; 4(1):e4324. PubMed ID: 19177168 [Abstract] [Full Text] [Related]
56. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME. J Psychiatr Res; 2008 Jan 15; 42(1):22-34. PubMed ID: 17445831 [Abstract] [Full Text] [Related]
57. Thyroid hormones affect recovery from depression during antidepressant treatment. Pae CU, Mandelli L, Han C, Ham BJ, Masand PS, Patkar AA, Steffens DC, De Ronchi D, Serretti A. Psychiatry Clin Neurosci; 2009 Jun 15; 63(3):305-13. PubMed ID: 19566761 [Abstract] [Full Text] [Related]
58. Immune-endocrine host response to endotoxin in major depression. Vedder H, Schreiber W, Schuld A, Kainz M, Lauer CJ, Krieg JC, Holsboer F, Pollmächer T. J Psychiatr Res; 2007 Jun 15; 41(3-4):280-9. PubMed ID: 17045296 [Abstract] [Full Text] [Related]
59. Biological markers of melancholia and reclassification of depressive disorders. Greden JF. Encephale; 1982 Jun 15; 8(2):193-202. PubMed ID: 6809444 [Abstract] [Full Text] [Related]
60. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gastó C. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr 30; 33(3):463-9. PubMed ID: 19302831 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]